Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0001209191-21-068920 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-12-09	2021-12-07	RXRX	Borgeson Blake	Dir	S - Sale	$20.31	-9,625	7.68M	-0.1%	-$195.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-12-07	S	D	400	$21.03	7,669,841	D	—	—	(F4) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.99 to $21.05 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-12-07	S	D	7,725	$20.38	7,670,241	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $19.98 to $20.97 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
3	Common	Class A Common Stock	2021-12-07	S	D	1,500	$19.78	7,677,966	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.98 to $19.97 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.